Wahed Invest LLC Horizon Therapeutics Public LTD CO Transaction History

Wahed Invest LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $27,120 - $31,712	274 Added 8.49%	3,503 $405,000
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $45,761 - $53,380	475 Added 17.25%	3,229 $332,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $4,936 - $5,221	-46 Reduced 1.64%	2,754 $300,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $13,476 - $24,580	216 Added 8.36%	2,800 $318,000
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $10,841 - $15,579	184 Added 7.67%	2,584 $160,000

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $13,339 - $19,548	-168 Reduced 6.54%	2,400 $191,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $3,716 - $4,721	-43 Reduced 1.65%	2,568 $270,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $257,340 - $313,085	2,611 New	2,611 $281,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

Stay updated on Wahed Invest LLC with notifications on news.